By crosslinking the transcriptomes of the MKRN1- and AGC1-deficient CRC cells, we identified that DEGs were primarily enriched in pathways related to mitochondrial dysfunction, antioxidant responses, and tumor drug resistance. This evidence concerns the gene MKRN1 and colorectal carcinoma.